Keyphrases
Activator protein-1 (AP-1)
11%
Baseline Data
11%
Beneficial Effects
11%
Blood Pressure
11%
Canagliflozin
44%
Cardiac Effects
11%
Cardiac Efficiency
100%
Cardiac Function
11%
Cardiac Outcomes
11%
Cardiac Work
11%
Cardiomyocytes
11%
Cardioprotection
33%
Cariporide
44%
Chronic Treatment
11%
Circumflex Coronary Artery
11%
Complete Occlusion
11%
Diastolic Filling
11%
Dose Effect
11%
Frank-Starling Relationship
11%
Glucose-lowering Drugs
11%
Heart Rate
11%
Induced Pluripotent Stem Cells (iPSCs)
11%
Infarction
11%
Intravenous Infusion
11%
Invasive Hemodynamics
11%
Ion Exchanger
100%
Ischemia
44%
Left Anterior Descending Artery
11%
Left Circumflex Artery
11%
Myocardial Infarction
11%
Myocardial Ischemia
100%
Myocardial Oxygen Consumption
11%
Na +
100%
NHE Inhibitors
11%
NHE1
88%
Occlusion
11%
Protective Effect
11%
Reperfusion
22%
Short Time Scale
11%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Stroke Work
11%
Swine
33%
Work Efficiency
22%
Medicine and Dentistry
Apoplexy
12%
Artery
12%
Artery Blood Flow
12%
Blood Pressure
12%
Canagliflozin
50%
Cardiac Muscle Cell
12%
Cariporide
50%
Coronary Artery
12%
Dimethyl Sulfoxide
12%
Heart Function
12%
Heart Muscle Ischemia
100%
Heart Muscle Oxygen Consumption
12%
Heart Work
12%
Hemodynamic
12%
Induced Pluripotent Stem Cell
12%
Infarction
12%
Intravenous Drug Administration
12%
Ischemia
50%
Myocardial Infarction
12%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Sodium Ion
100%
Pharmacology, Toxicology and Pharmaceutical Science
Canagliflozin
50%
Cariporide
50%
Cerebrovascular Accident
12%
Dimethyl Sulfoxide
12%
Heart Infarction
12%
Heart Muscle Ischemia
100%
Infarction
12%
Ischemia
50%
Pig
37%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Sodium Ion
100%
Starling
12%